Official Journal of
East European Branch of
CardiOncology Society
Grzegorz Piotrowski

Otrzymano/Received: 5.09.2020. Zaakceptowano/Accepted: 3.10.2020

Acute coronary syndrome in cancer patients. Part II: invasive and conservative treatment options, takotsubo syndrome problem

Acute coronary syndrome in cancer patients. Part II: invasive and conservative treatment options, takotsubo syndrome problem OncoReview 2020; 3(39): 89-97. DOI: 10.24292/01.OR.320301020
STRESZCZENIE

Acute coronary syndrome (ACS) and oncological disease are more frequently observed in the general population as discussed in the part I of this article. Treatment of myocardial infarction in oncological patients becomes a real struggle for clinicians, especially that the data from clinical trials including cancer patients with ACS are very limited. The choice of treatment modality should consider many existing factors considering the type of ACS – non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction, patient’s condition, type of cancer and oncological treatment applied. Taking into consideration above mentioned factors, clinicians have to face three therapeutic options: invasive, conservative or combination of both in order to choose the best and most beneficial treatment. This article summarizes the current therapeutic approach to the management of ACS in cancer patients.

ABSTRACT

Acute coronary syndrome (ACS) and oncological disease are more frequently observed in the general population as discussed in the part I of this article. Treatment of myocardial infarction in oncological patients becomes a real struggle for clinicians, especially that the data from clinical trials including cancer patients with ACS are very limited. The choice of treatment modality should consider many existing factors considering the type of ACS – non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction, patient’s condition, type of cancer and oncological treatment applied. Taking into consideration above mentioned factors, clinicians have to face three therapeutic options: invasive, conservative or combination of both in order to choose the best and most beneficial treatment. This article summarizes the current therapeutic approach to the management of ACS in cancer patients.

POPRZEDNIE NUMERY